BioHealth News Archive
Precision For Medicine Launches Biospecimen Solutions Offering With Acquisition Of ProMedDx And GLAS
Precision for Medicine, part of Precision Medicine Group, announced it has acquired leading biospecimen providers ProMedDx and GLAS, significantly expanding its capabilities and expertise…
Read MoreQ & A with Brian Darmody–Growing a Maryland research business | The Business Monthly
What’s it like having two high-profile jobs at once? Ask Brian Darmody, who’s been serving the University of Maryland College Park (UMCP) since 1982…
Read MoreGlobal VC Firm NEA Makes First-Ever Israeli MedTech Investment In Magenta Medical | News Brief
Magenta Medical, the heart failure solutions developer based on proprietary miniaturized blood pump technology announced they have raised funds Monday in a round led…
Read MoreRoche extends $4.3B Spark tender offer yet again. What are watchdogs so worried about? | FiercePharma
You might have lost count of how many times Roche has extended the tender offer period for shares of Spark Therapeutics. As of Wednesday,…
Read MoreMontgomery County Economic Development Corporation – Maryland is excited to be attending Site Selectors Guild Fall Forum
Montgomery County Economic Development Corporation - Maryland is excited to be attending Site Selectors Guild Fall Forum this September 9-11th in Dallas! We're looking…
Read MoreUniversity System of Maryland Names Claire Broido Johnson Managing Director of the Maryland Momentum Fund – University of Maryland, Baltimore
The University System of Maryland (USM) has named Claire Broido Johnson, MBA, as Managing Director of the Maryland Momentum Fund (MMF), a $10 million…
Read MoreAnne Lindblad, President & CEO Emmes | CEO’s You Should Know | HOT 99.5
Anne Lindblad, PhD, joined Emmes in 1982 as a Biostatistician and currently serves as the President and CEO of the company. She has supported…
Read MoreEmergent BioSolutions Announces Exercise by BARDA of the First Contract Option, Valued at $261 Million, to Procure Doses of AV7909 Anthrax Vaccine Candidate for the Strategic National Stockpile | Emergent BioSolutions Inc.
Emergent BioSolutions Inc. (NYSE:EBS) announced today that the Biomedical Advanced Research and Development Authority (BARDA) has exercised its first contract option valued at $261…
Read MoreThe Johns Hopkins Hospital Ranked #3 Nationally by U.S. News
The Johns Hopkins Hospital is once again ranked #3 in the nation out of more than 4,600 hospitals reviewed for U.S. News & World…
Read MoreMayo to announce new med-accelerator partnership with Boston Scientific | MPR News
Mayo Clinic and medical device giant Boston Scientific are slated to announce a new med-tech accelerator Monday. The collaboration will be located in One…
Read MoreJohns Hopkins University wins grant to spur economic development in Maryland’s health field – Baltimore Sun
The U.S. Economic Development Administration awarded more than $600,000 to a division of Johns Hopkins University on Tuesday to increase economic development in the…
Read Moregel-e Inc., announces Breakthrough Status Designation from the U.S. Food and Drug Administration (FDA) for its first internal-use flowable device
gel-e is developing a line of advanced hemostatic and wound treatment products that address unmet needs from the operating room to the backyard. Following…
Read MoreBaltimore area needs a regional economic development strategy – Baltimore Sun
In the last five to 10 years, it would seem as though Baltimore is finally emerging (at least economically) — from its slow, multi-decade…
Read MoreRed Wine Compound for Treating Depression and Anxiety?
A nice, relaxing glass of Bordeaux or Cabernet might easily seem like the perfect treatment for an anxious or slightly depressed state. Though, the…
Read MoreCollege of Science – George Mason University Patent with Applications to Breast Cancer Treatment Licensed by Targeted Pharmaceuticals, a Cannabinoid-Based Drug Discovery Company
A patent granted to George Mason University Research Foundation Inc., which describes a novel treatment method for pre-invasive breast cancer, has been exclusively licensed…
Read More